OCQUILA
Dead / Cancelled — Cancelled — Section 8 (as of 02 May 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87211780
- Registration number
- 5583284
- Mark type
- Stylized text
- Filed
- 21 Oct 2016
- Published for opposition
- 05 Jun 2018
- Registered
- 16 Oct 2018
- Attorney of record
- Roberta S. Bren
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science; enzymes for scientific and research purposes; biochemicals, namely, precursors for in vitro genetic engineering use; biochemicals, namely, polypeptides for in vitro research use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemicals for use in the purification of proteins for in vitro use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; micro-organisms for laboratory and scientific research use, viruses for laboratory and scientific research use, cell cultures for laboratory and scientific research use, plasmids and cultures of micro-organisms for laboratory and scientific research use, nucleic acid sequences for laboratory and scientific research use, cloning vehicles in the nature of plasmids, microbes and chemical reagents for DNA cloning for laboratory and scientific research use, chemicals for laboratory and scientific research and development use in biotechnology research and development and recombinant nucleic acid variations thereof for laboratory and scientific research use, all of the foregoing for in-vivo use; biochemical preparations for manufacture of viral, retroviral and non-viral vectors for medical research and pharmaceutical research and development; biochemical preparations for the manufacture of viral, retroviral and non-viral vectors, all for medical purposes in gene therapy, namely for the prevention of genetic or cell-based conditions
- Class 005 — Pharmaceuticals: Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals for the treatment of genetic or cell based conditions; small molecules, vaccines, biologics, enzymes and enzyme preparations all for medical purposes in connection with gene therapy for the treatment of genetic or cell based conditions; pharmaceuticals for medical purposes for the delivery of genes to cells for the treatment of genetic or cell based conditions; viral, retroviral and non-viral vectors, all for medical purposes in gene therapy, namely, for the treatment of genetic or cell based conditions; biochemical and chemical preparations for medical purposes in gene therapy, namely, for the treatment of genetic or cell based conditions
Owner
- Oxford BioMedica (UK) Limited, Oxford OX4 6LT, GB
- Oxford BioMedica (UK) Limited, Oxford OX4 6LT, GB
- Oxford BioMedica (UK) Limited, Oxford, GB
Prosecution history
- 02 May 2025 — CANCELLED SEC. 8 (6-YR)
- 16 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 07 Sept 2018 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 07 Aug 2018 — NOTICE OF ALLOWANCE CANCELLED
- 07 Sept 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Aug 2018 — TEAS DELETE 1(B) BASIS RECEIVED
- 31 Jul 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jun 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Jun 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Jun 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Jun 2018 — PUBLISHED FOR OPPOSITION
- 16 May 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 May 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 May 2018 — EXAMINER'S AMENDMENT ENTERED